Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) EPS (Basic): 2010-2024

Historic EPS (Basic) for OptimizeRx (OPRX) over the last 15 years, with FY2024 value amounting to -$1.1.

  • OptimizeRx's EPS (Basic) rose 10800.0% to $0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.04, marking a year-over-year increase of 10800.0%. This contributed to the annual value of -$1.1 for FY2024, which is 679.61% down from last year.
  • Per OptimizeRx's latest filing, its EPS (Basic) stood at -$1.1 for FY2024, which was down 679.61% from -$1.03 recorded in FY2023.
  • Over the past 5 years, OptimizeRx's EPS (Basic) peaked at $0.02 during FY2021, and registered a low of -$1.1 during FY2024.
  • Moreover, its 5-year median value for EPS (Basic) was -$0.64 (2022), whereas its average is -$0.58.
  • In the last 5 years, OptimizeRx's EPS (Basic) surged by 11333.33% in 2021 and then tumbled by 330000.0% in 2022.
  • OptimizeRx's EPS (Basic) (Annual) stood at -$0.15 in 2020, then skyrocketed by 113.33% to $0.02 in 2021, then crashed by 3300.0% to -$0.64 in 2022, then tumbled by 60.94% to -$1.03 in 2023, then decreased by 6.8% to -$1.1 in 2024.
  • Its EPS (Basic) was -$1.1 in FY2024, compared to -$1.03 in FY2023 and -$0.64 in FY2022.